<DOC>
	<DOCNO>NCT01562002</DOCNO>
	<brief_summary>The purpose study determine whether allogenic bone marrow stem cell transplant safe effective treatment limbus insufficiency syndrome versus allogenic limbus stem cell transplant .</brief_summary>
	<brief_title>Safety Study Stem Cell Transplant Treat Limbus Insufficiency Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<criteria>Male Female old 18 year . Signed Informed consent Negative pregnancy test inclusion potential childbearing female . Compromise contraceptive method trial potential childbearing female . Diagnosis Ocular Surface Failure due Limbus Insufficiency Syndrome , base publish characteristic corneal surface neovascularization , loss corneal transparency , epithelial irregularity , history punctate keratitis , erosion repetitive ulcer presence symptom confirm presence epithelial phenotype cell assess conjunctival impression cytology . Availability schedule visit study Uncontrolled systemic disease ( e.g . hypertension diabetes ) disease medical decision might put patient risk surgery followup examination may cause hazard data analysis . Active ocular infection eye . If infection cure , inclusion consider 30 day inactive infection since end . Alterations lid static / dynamic pathology ( e.g . severe dry eye syndrome ) except one originate Limbus Insufficience medical opinion might alter result . Any must correct 3 month prior patient inclusion , reconsider rescreening . Limbus insufficiency syndrome previously treat medical ( surgical ) procedures available . No availability schedule visit study . Any circumstance investigatorÂ´s opinion prevents patient inclusion even though normal inclusion exclusion criterion meet .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>limbus</keyword>
	<keyword>cornea</keyword>
	<keyword>insufficiency syndrome</keyword>
	<keyword>stem cell transplant</keyword>
</DOC>